What’s Inside the Q&A:

Location Decision Framework

How to evaluate tax environment, talent pools, and logistics when selecting your European base of operations.

Popular Hub Destinations

Why Ireland, Netherlands, UK, and Switzerland dominate biopharma headquarters choices and their specific advantages.

Regulatory Entity Considerations
Where to establish your Marketing Authorization Holder (MAH) and how it impacts your operational structure.

Hub-and-Spoke Models
Strategic approaches to combining central headquarters with local market presence across multiple countries.